Jennifer Gudeman
Chief Tech/Sci/R&D Officer bei AVADEL PHARMACEUTICALS PLC
Profil
Jennifer Gudeman is currently the Vice President-Medical & Clinical Affairs at Avadel Pharmaceuticals Plc since 2020.
Prior to this, she worked as the Director-Medical Affairs at AMAG Pharma USA, Inc. and as the Vice President-Medical Affairs at AMAG Pharmaceuticals, Inc. Dr. Gudeman completed her undergraduate degree in 1999 and her doctorate degree in 2000 from St. Louis College of Pharmacy.
Aktive Positionen von Jennifer Gudeman
Unternehmen | Position | Beginn |
---|---|---|
AVADEL PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 07.12.2020 |
Ehemalige bekannte Positionen von Jennifer Gudeman
Unternehmen | Position | Ende |
---|---|---|
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Jennifer Gudeman
St. Louis College of Pharmacy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AVADEL PHARMACEUTICALS PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |